Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye surgery showdown: one step or two for retinal detachment?

NCT ID NCT06997874

Symptom relief Sponsor: Queen's University, Belfast Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at the best way to fix a detached retina, a serious eye problem that can cause vision loss. It compares doing one surgery (vitrectomy) alone versus doing it together with cataract surgery at the same time. The goal is to see which approach gives better vision, fewer complications, and is more cost-effective for adults aged 50 and older.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 276 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults ≥50 years of age * Non-highly myopic (\< -6 diopters; ≤26.5 mm axial length) phakic RRD * Naive to previous vitreoretinal surgery * Pars plana vitrectomy is planned to repair their RRD Exclusion Criteria: * Presence of a "formed/established cataract." A "formed/established cataract" is defined as a cataract that, based on the Age-Related Eye Disease Study (AREDS) Research Group, is graded as nuclear sclerosis of \>3 and/or if there is an anterior cortical cataract and/or a subcapsular posterior cataract involving the visual axis. * Pseudophakia or aphakia * High myopia (≥ -6 diopters; \>26.5 mm axial length) * Giant retinal tear (i.e. presence of one or more retinal tears of \>3 clock hours in size) * Retinal dialysis * Inclusion in an investigational drug study * Declined consent for participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rhegmatogenous retinal detachment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cataract rhegmatogenous retinal detachment

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rhegmatogenous retinal detachment

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    31 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Barts Health NHS Trust

    RECRUITING

    London, United Kingdom

  • Belfast Health and Social Care Trust

    RECRUITING

    Belfast, United Kingdom

  • Bradford Teaching Hospitals NHS Foundation Trust

    RECRUITING

    Bradford, United Kingdom

  • Buckinghamshire Healthcare NHS Trust

    RECRUITING

    Aylesbury, United Kingdom

  • County Durham and Darlington NHS Foundation Trust

    RECRUITING

    Darlington, United Kingdom

  • Guys & St Thomas NHS Foundation Trust

    RECRUITING

    London, United Kingdom

  • Hull University Teaching Hospitals NHS Trust

    RECRUITING

    Hull, United Kingdom

  • Imperial College NHS Trust

    NOT_YET_RECRUITING

    London, United Kingdom

  • King's College Hospital NHS Foundation Trust

    RECRUITING

    London, United Kingdom

  • Liverpool University Hospitals NHS Foundation Trust

    RECRUITING

    Liverpool, United Kingdom

  • Manchester University NHS Foundation Trust

    RECRUITING

    Manchester, United Kingdom

  • Mid & South Essex NHS Foundation Trust

    RECRUITING

    Westcliff-on-Sea, United Kingdom

  • Moorfields Eye Hospital NHS Foundation Trust

    RECRUITING

    London, United Kingdom

  • NHS Greater Glasgow & Clyde

    RECRUITING

    Glasgow, United Kingdom

  • NHS Lothian

    NOT_YET_RECRUITING

    Edinburgh, United Kingdom

  • Newcastle Upon Tyne Hospitals NHS Foundation Trust

    RECRUITING

    Newcastle upon Tyne, United Kingdom

  • Norfolk and Norwich University Hospital NHS Foundation Trust

    NOT_YET_RECRUITING

    Norwich, United Kingdom

  • Nottingham University Hospital NHS Trust

    NOT_YET_RECRUITING

    Nottingham, United Kingdom

  • Oxford University Hospitals NHS Foundation Trust

    RECRUITING

    Oxford, United Kingdom

  • Royal Berkshire NHS Foundation Trust

    RECRUITING

    Reading, United Kingdom

  • Sandwell and West Birmingham Hospitals NHS Trust

    RECRUITING

    Birmingham, United Kingdom

  • Sheffield Teaching Hospitals NHS Foundation Trust

    RECRUITING

    Sheffield, United Kingdom

  • South Tees Hospitals NHS Foundation Trust

    RECRUITING

    Middlesbrough, United Kingdom

  • South Tyneside and Sunderland NHS Trust

    RECRUITING

    Sunderland, United Kingdom

  • The Leeds Teaching Hospitals NHS Trust

    NOT_YET_RECRUITING

    Leeds, United Kingdom

  • The Royal Wolverhampton NHS Trust

    NOT_YET_RECRUITING

    Wolverhampton, United Kingdom

  • University Hospital Southampton NHS Foundation Trust

    RECRUITING

    Southampton, United Kingdom

  • University Hospitals Bristol NHS Foundation Trust

    RECRUITING

    Bristol, United Kingdom

  • University Hospitals Leicester NHS Trust

    RECRUITING

    Leicester, United Kingdom

  • Wirral University Teaching Hospital NHS Foundation Trust

    RECRUITING

    Metropolitan Borough of Wirral, United Kingdom

  • York and Scarborough Teaching Hospitals NHS Foundation Trust

    RECRUITING

    York, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.